PTPRC and Miyoshi myopathy: This observation is consistent with previous studies demonstrating that patients with CD45 negative MM had poorer OS compared to patients with CD45 positive MM, suggesting that the CD45 negative MM phenotype may be a marker of progressive disease [48, 49].